The SGLT2 Inhibitor Dapagliflozin Increases the Oxidation of Ingested Fatty Acids to Ketones in Type 2 Diabetes.

Overview of attention for article published in Diabetes Care, March 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

reddit: 1 Redditor

Readers on

mendeley: 36 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 858 followers.

RT @RevistaMFSamfyc: El inhibidor de SGLT2 dapagliflozina aumenta la oxidación a cetonas de los ácidos grasos ingeridos en la diabetes tipo…

El inhibidor de SGLT2 dapagliflozina aumenta la oxidación a cetonas de los ácidos grasos ingeridos en la diabetes tipo 2 https://t.co/jEkYm6p5gO PMID 35312749

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.